Recent Publications
Representing Publications from RCB Division (2021- )
- Chang CY, Wang J, Zhao Y, Liu J, Yang X, Yue X, Wang H, Zhou F, Inclan-Rico JM, Ponessa JJ, Xie P, Zhang L, Siracusa MC, Feng Z, Hu W. Tumor suppressor p53 regulates intestinal type 2 immunity. Nat Commun. 2021;12(1):3371. Epub 2021/06/09. doi: 10.1038/s41467-021-23587-x. PubMed PMID: 34099671; PMCID: PMC8184793.
- Choi WS, Liu B, Shen Z, Yang W. Structure of human BCCIP and implications for binding and modification of partner proteins. Protein Sci. 2021;30(3):693-9. Epub 2021/01/17. doi: 10.1002/pro.4026. PubMed PMID: 33452718; PMCID: PMC7888581.
- Foo TK, Vincelli G, Huselid E, Her J, Zheng H, Simhadri S, Wang M, Huo Y, Li T, Yu X, Li H, Zhao W, Bunting SF, Xia B. ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G(2)-M Checkpoint Maintenance. Cancer Res. 2021;81(18):4676-84. Epub 2021/07/25. doi: 10.1158/0008-5472.Can-20-2723. PubMed PMID: 34301763; PMCID: PMC8448966.
- Hu W, Feng Z. Hypothermia Is a Potential New Therapy for a Subset of Tumors with Mutant p53. Cancer Res. 2021;81(14):3762-3. Epub 2021/07/17. doi: 10.1158/0008-5472.Can-21-1025. PubMed PMID: 34266914.
- Huo Y, Selenica P, Mahdi AH, Pareja F, Kyker-Snowman K, Chen Y, Kumar R, Da Cruz Paula A, Basili T, Brown DN, Pei X, Riaz N, Tan Y, Huang YX, Li T, Barnard NJ, Reis-Filho JS, Weigelt B, Xia B. Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development. NPJ Breast Cancer. 2021;7(1):45. Epub 2021/04/25. doi: 10.1038/s41523-021-00253-5. PubMed PMID: 33893322; PMCID: PMC8065161.
- Hussein S, Khanna P, Yunus N, Gatza ML. Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. Cancers (Basel). 2021;13(19). Epub 2021/10/14. doi: 10.3390/cancers13194808. PubMed PMID: 34638293; PMCID: PMC8508306.
- Jariwala N, Mehta GA, Bhatt V, Hussein S, Parker KA, Yunus N, Parker JS, Guo JY, Gatza ML. CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer. NAR Cancer. 2021;3(3):zcab035. Epub 2021/09/14. doi: 10.1093/narcan/zcab035. PubMed PMID: 34514415; PMCID: PMC8428294.
- Kang Z, Fu P, Alcivar AL, Fu H, Redon C, Foo TK, Zuo Y, Ye C, Baxley R, Madireddy A, Buisson R, Bielinsky AK, Zou L, Shen Z, Aladjem MI, Xia B. BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage. Nat Commun. 2021;12(1):5966. Epub 2021/10/15. doi: 10.1038/s41467-021-26227-6. PubMed PMID: 34645815; PMCID: PMC8514439.
- Khella CA, Mehta GA, Mehta RN, Gatza ML. Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer. J Pers Med. 2021;11(2). Epub 2021/03/07. doi: 10.3390/jpm11020149. PubMed PMID: 33669749; PMCID: PMC7922242.
- Liu J, Zhang C, Wang X, Hu W, Feng Z. Tumor suppressor p53 cross-talks with TRIM family proteins. Genes Dis. 2021;8(4):463-74. Epub 2021/06/29. doi: 10.1016/j.gendis.2020.07.003. PubMed PMID: 34179310; PMCID: PMC8209353.
- Lu H, Ye C, Liu J, Rabson AB, Verzi M, De S, Shen Z. Requirement of Bccip for the Regeneration of Intestinal Progenitors. Am J Pathol. 2021;191(1):66-78. Epub 2020/10/12. doi: 10.1016/j.ajpath.2020.09.009. PubMed PMID: 33039352; PMCID: PMC7857062.
- Ma H, Kang Z, Foo TK, Shen Z, Xia B. Disrupted BRCA1-PALB2 Interaction Induces Tumor Immunosuppression and T-Lymphocyte Infiltration in Hepatocellular Carcinoma Through cGAS-STING Pathway. Hepatology. 2022. Epub 2022/01/11. doi: 10.1002/hep.32335. PubMed PMID: 35006619.
- Zhang C, Liu J, Wang J, Hu W, Feng Z. The emerging role of leukemia inhibitory factor in cancer and therapy. Pharmacol Ther. 2021;221:107754. Epub 2020/12/02. doi: 10.1016/j.pharmthera.2020.107754. PubMed PMID: 33259884; PMCID: PMC8084904.
- Zhang C, Liu J, Wang J, Zhang T, Xu D, Hu W, Feng Z. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer. Front Cell Dev Biol. 2021;9:648808. Epub 2021/03/09. doi: 10.3389/fcell.2021.648808. PubMed PMID: 33681231; PMCID: PMC7930565.